Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Corey

Showing results (51-60 of 551) with videos related to

Pageof 56
Sort By:
Open Forum Infectious Diseases|July 15, 2020
An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2Joshua T Schiffer, Christine Johnston, Anna Wald, et al.
BMC Infectious Diseases|October 18, 2005
Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISARhoda Ashley Morrow, David Friedrich, Amalia Meier, et al.
Ebiomedicine|February 5, 2016
Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical ModelsDobromir Dimitrov, James G Kublin, Scott Ramsey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2004
The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemicsLawrence Corey, Anna Wald, Connie L Celum, et al.
The Journal of Infectious Diseases|November 26, 2002
Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppressionTimothy Schacker, Judith Zeh, Huilin Hu, et al.
Sexually Transmitted Diseases|February 5, 2003
Natural history of genital herpes simplex virus type 1 infectionRebecca Engelberg, David Carrell, Elizabeth Krantz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapyW Garrett Nichols, Katherine A Guthrie, Lawrence Corey, et al.
Antimicrobial Agents and Chemotherapy|September 11, 2013
Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agentsJoshua T Schiffer, David A Swan, Lawrence Corey, et al.
Lancet (London, England)|April 10, 2022
COVID-19 vaccination and HIV-1 acquisition - Authors' replySusan P Buchbinder, M Juliana McElrath, Carl Dieffenbach, et al.
The Journal of Infectious Diseases|May 18, 2005
Longitudinal analysis of herpes simplex virus-specific CD4+ cell clonotypes in infected tissues and bloodSerge Barcy, Meei-Li Huang, Lawrence Corey, et al.
Pageof 56

Showing results (51-60 of 551) with videos related to

Sort By:
Pageof 56
Open Forum Infectious Diseases|July 15, 2020
An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2Joshua T Schiffer, Christine Johnston, Anna Wald, et al.
BMC Infectious Diseases|October 18, 2005
Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISARhoda Ashley Morrow, David Friedrich, Amalia Meier, et al.
Ebiomedicine|February 5, 2016
Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical ModelsDobromir Dimitrov, James G Kublin, Scott Ramsey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2004
The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemicsLawrence Corey, Anna Wald, Connie L Celum, et al.
The Journal of Infectious Diseases|November 26, 2002
Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppressionTimothy Schacker, Judith Zeh, Huilin Hu, et al.
Sexually Transmitted Diseases|February 5, 2003
Natural history of genital herpes simplex virus type 1 infectionRebecca Engelberg, David Carrell, Elizabeth Krantz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapyW Garrett Nichols, Katherine A Guthrie, Lawrence Corey, et al.
Antimicrobial Agents and Chemotherapy|September 11, 2013
Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agentsJoshua T Schiffer, David A Swan, Lawrence Corey, et al.
Lancet (London, England)|April 10, 2022
COVID-19 vaccination and HIV-1 acquisition - Authors' replySusan P Buchbinder, M Juliana McElrath, Carl Dieffenbach, et al.
The Journal of Infectious Diseases|May 18, 2005
Longitudinal analysis of herpes simplex virus-specific CD4+ cell clonotypes in infected tissues and bloodSerge Barcy, Meei-Li Huang, Lawrence Corey, et al.
Pageof 56